Milestone PharmaceuticalsMIST
13F holders, Q2 2025 (June 30)43holders
9new positions
10sold out
$1.94avg. 13F price*
At the end of Q2 2025, 43 institutions reported holding Milestone Pharmaceuticals Inc. (MIST) in their 13F filings, unchanged from Q1 2025. 9 opened new positions and 10 sold out. The largest holders were RTW Investments, LP ($4.9M), Propel Bio Management, LLC ($3.5M) and Alta Fundamental Advisers LLC ($2.7M).
- Company
- Milestone Pharmaceuticals Inc.
- CUSIP
- 59935V107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $621K |
| Exits | 10 | $622K |
All 13F filers, Q1 2025 → Q2 2025: 1,277,393 shares bought and 1,284,057 shares sold, net −6,664 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 43 holders
| RTW Investments, LP | 0.07% | No change | 2,506,102 | $4.9M |
| Propel Bio Management, LLC | 4.22% | Add +23.4% | 1,791,557 | $3.5M |
| Alta Fundamental Advisers LLC | 1.51% | Reduce -2.0% | 1,398,977 | $2.7M |
| BML Capital Management, LLC | 1.69% | No change | 1,136,091 | $2.2M |
| Simplify Asset Management Inc. | 0.12% | Add +16.5% | 990,000 | $1.9M |
| Morgan Stanley | 0.00% | Reduce -15.3% | 820,421 | $1.6M |
| Toronto Dominion Bank | 0.00% | No change | 750,000 | $1.5M |
| Lion Point Capital, LP | 7.23% | No change | 548,806 | $1.1M |
| Bleichroeder LP | 0.24% | No change | 500,000 | $970K |
| UBS Group AG | 0.00% | Add +189.3% | 322,648 | $626K |
| XTX Topco Ltd | 0.01% | Add +209.5% | 160,963 | $312K |
| Valeo Financial Advisors, LLC | 0.01% | Add +553.5% | 130,699 | $254K |
| Goldman Sachs Group Inc. | 0.00% | New | 119,449 | $232K |
| Cascades Capital Asset Management, LLC | 0.07% | New | 67,135 | $130K |
| Susquehanna International Group, LLP | 0.00% | Add +2.1% | 63,369 | $123K |
| Northern Trust Corp. | 0.00% | No change | 53,001 | $103K |
| Raymond James Financial Inc. | 0.00% | Add +30.1% | 43,235 | $84K |
| Focus Partners Wealth | 0.00% | New | 36,000 | $70K |
| Royal Bank of Canada | 0.00% | Add +256.0% | 35,600 | $69K |
| Jane Street Group, LLC | 0.00% | New | 31,933 | $62K |
| Group One Trading LLC | 0.00% | Reduce -77.2% | 31,616 | $61K |
| Safeguard Investment Advisory Group, LLC | 0.01% | No change | 25,044 | $49K |
| Creative Planning | 0.00% | Add +74.6% | 23,410 | $45K |
| Scientech Research LLC | 0.01% | Reduce -16.8% | 19,064 | $37K |
| National Bank of Canada | 0.00% | No change | 18,700 | $36K |
| State Street Corp. | 0.00% | Reduce -1.6% | 18,246 | $35K |
| Geode Capital Management, LLC | 0.00% | Reduce -9.6% | 17,958 | $35K |
| Walleye Capital LLC | 0.00% | Reduce -83.6% | 15,109 | $29K |
| Mercer Global Advisors Inc. | 0.00% | New | 15,100 | $29K |
| Journey Strategic Wealth LLC | 0.00% | No change | 15,000 | $29K |
| Virtu Financial LLC | 0.00% | New | 14,761 | $29K |
| Bay Rivers Group | 0.01% | New | 14,321 | $28K |
| Beta Wealth Group, Inc. | 0.01% | No change | 14,127 | $27K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 13,000 | $25K |
| LPL Financial LLC | 0.00% | Reduce -90.1% | 11,050 | $21K |
| Mariner, LLC | 0.00% | New | 11,000 | $21K |
| Jones Financial Companies LLLP | 0.00% | No change | 11,000 | $20K |
| Taylor Financial Group, Inc. | 0.01% | New | 10,000 | $19K |
| Ancora Advisors LLC | 0.00% | No change | 10,000 | $19K |
| US Bancorp \de | 0.00% | No change | 3,200 | $6K |
| Oliver Lagore Vanvalin Investment Group | 0.00% | — | 100 | $80 |
| Bank of America Corp. | 0.00% | Reduce -100.0% | 8 | $16 |
| SBI Securities Co., Ltd. | 0.00% | Add +50.0% | 6 | $12 |
"% of holder's portfolio" is MIST's weight in each manager's 13F, not the share of Milestone Pharmaceuticals Inc. the manager owns.